David J. Pinato

, United Kingdom


Presentations

Treatment-related toxicity predicts for improved outcome in patients with hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitor therapy. 27 August 2020 12:15 - 12:30 More ...
Optimisation and qualification of tumour mutational burden (TMB) by targeted next-generation sequencing (TNGS) as a clinically applicable biomarker in hepatocellular carcinoma (HCC) 27 August 2020 12:30 - 12:30 More ...